Caravelle's Chairman of the Board and CEO, Dr. Guohua Zhang, invited to Davos Summit 2024
--Milestone Initiative on Ocean Carbon Neutral Sustainability with Fortune 500 CEOs and ESG Leaders SINGAPORE, Jan. 24, 2024 /PRNewswire/ -- Dr Guohua Zhang, Chairman and CEO of Caravelle International Group (Nasdaq: CACO) , the world's leading...
CICC Attends the 17th Asian Financial Forum
Contributing to a Sustainable Development BEIJING, Jan. 24, 2024 /PRNewswire/ -- On January 24th, 2024, the two-day 17th Asian Financial Forum 2024 (AFF), co-organised by the Hong Kong Special Administrative Region (HKSAR) Government and the Hong...
HOUSE OF ROSE PROFESSIONAL ANNOUNCES 2024 BREAK THE CEILING TOUCH THE SKY® WORLD TOUR
NEW YORK, Jan. 24, 2024 /PRNewswire/ -- House of Rose Professional Pte Ltd. (HORP) today announced the launch of its 2024 World Tour of Break the ceiling touch the sky® - the success and leadership summit for women with multiple international...
ESR Announces the Launch of the World's First Qi2 Car Charger
The latest charging solution from ESR is bringing the power of Qi2 charging to the car WILMINGTON, Del., Jan. 24, 2024 /PRNewswire/ -- ESR, the top-selling brand for MagSafe accessories on Amazon, is announcing the launch of its new Qi2 car charger...
CES 2024: EDINT's Mobile-based Proctoring Service "Proctormatic" Sets Stage for Global Expansion
DAEJEON, South Korea, Jan. 24, 2024 /PRNewswire/ -- South Korean tech startup EDINT significantly impacted the Consumer Electronics Show (CES) 2024, held from January 9th to 12th in Las Vegas. The company stood out among the 20 participating...
WestGene Spearheads Oncology Breakthroughs at the 3rd mRNA-Based Therapeutics Summit
CHENGDU, China, Jan. 24, 2024 /PRNewswire/ -- Kicking off the New Year with remarkable achievements, Chengdu-based WestGene made a significant impact at the 3rd mRNA-Based Therapeutics Summit in Berlin, Germany. Renowned for her pivotal role in mRNA...
![Positive Xanamem® human PET study published in the Journal of Alzheimer's Disease demonstrating robust CNS[1] target enzyme occupancy](http://prnewswire.vietreader.com/thumb/190x300/2024-01/positive-xanamem-human-pet-study-published-in-the-journal-of-alzheimers-disease-demonstrating-robust-cns1-target-enzyme-occupancy-1.jpg)
Positive Xanamem® human PET study published in the Journal of Alzheimer's Disease demonstrating robust CNS[1] target enzyme occupancy
The study confirms that Xanamem is a brain-penetrant inhibitor of the tissue cortisol synthesis enzyme, 11 β -HSD1, with high levels of target occupancy at doses as low as 5 mg SYDNEY, Jan. 24, 2024 /PRNewswire/ -- Actinogen Medical Limited (ASX:...
LG Innotek accelerating its entry into autonomous driving and XR markets
Investing in a Taiwanese lens manufacturing corporation to enhance business competitiveness and supply chain. Entered into a strategic partnership to cooperate in the area of optical components. CEO Moon Hyuk-soo, "We will provide differentiated...